A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brian Gazzard, MD
St. Stephen's Trust
Study Chair - David A Cooper, MD
Kirby Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Interzonal General de Agudos, Oscar Alende
Buenos Aires, Mar Del Plata Provincia, Argentina
- Caici
Buenos Aires, Rosario Provincia de Sante Fe, Argentina
- Funcei
Buenos Aires, Argentina
- Hospital General de Agudos 'Teodoro Alvarez'
Buenos Aires, Argentina
- Hospital Italiano
Buenos Aires, Argentina
- Hospital J.M. Ramos Mejia
Buenos Aires, Argentina
- Hospital Prof. Alejandro Posadas
Buenos Aires, Argentina
- Hospital de Infecciosas Fj Muniz
Buenos Aires, Argentina
- Hospital Rawson
Córdoba, Argentina
- Hospital Central
Mendoza, Argentina
- Liverpool Hospital
Liverpool, New South Wales, Australia
- Albion Street Centre
Sydney, New South Wales, Australia
- St Vincent'S Hospital
Sydney, New South Wales, Australia
- Centre Clinic
Melbourne, Victoria, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Hospital San Borja-Arriaran
Santiago, Chile
- Hospital de la Universidad Catolica Pontificia
Santiago, Chile
- Hopital Saint-Louis
Paris, France
- Medical Group Practice
Berlin, Germany
- J W Goethe Universitat
Frankfurt, Germany
- Queen Elizabeth Hospital
Hong Kong, Kowloon, Hong Kong
- Institute of Infectious Diseases
Pune, Pune, India
- Yrg Care
Chennai, India
- Mater Misericordiae-Dublin
Dublin, Ireland
- Hospital Pelau Pinang
Kuala Lumpur, Malaysia
- Hospital Sungai Buloh
Kuala Lumpur, Malaysia
- University of Malaysia
Kuala Lumpur, Malaysia
- Hospital General de Guadalajara
Guadalajara, Mexico
- Hospital General de Leon
León, Mexico
- Instituto Nacional de Ciencias Medicas Y Nutricion "salvado Zubiran"
Mexico City, Mexico
- Auckland Hospital
Grafton, Auckland, New Zealand
- Evangel Hospital (ecwa)
Jos, Plateau State, Nigeria
- Jos University Teaching Hospital (juth)
Jos, Plateau State, Nigeria
- Plateau State Specialist Hospital
Jos, Plateau State, Nigeria
- Hospital Almenara
Lima, Peru
- Impacta/hospital Dos de Mayo
Lima, Peru
- Instituto de Medicina Tropical Alexander Von Humboldt, Universidad Peruana Cayetano Heredia
Lima, Peru
- Via Libre
Lima, Peru
- Tan Tock Seng Hospital
Singapore, Singapore
- Josha Research
Bloemfontein, South Africa
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- 30 Sept 2012
- Completion
- 31 Aug 2013
- Last update posted
- 27 Mar 2026
- Registered enrollment
- 558
- Registry id
- NCT00931463
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.